T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients

C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP

(2017) Roberto Carnevale et al.   Scientific Reports

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseClinical Perspective

(2016) Francesco Franchi et al.   CIRCULATION

T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients

(2016) Speranza Rubattu et al.   Journal of Cardiovascular Medicine

Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases

(2014) Speranza Rubattu et al.   CLINICAL SCIENCE

2014 ESC/EACTS Guidelines on myocardial revascularization

(2014)   EUROPEAN HEART JOURNAL

The C2238/αANP Variant Is a Negative Modulator of Both Viability and Function of Coronary Artery Smooth Muscle Cells

(2014) Speranza Rubattu et al.   PLoS One

C2238 Atrial Natriuretic Peptide Molecular Variant Is Associated With Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling

(2013) Sebastiano Sciarretta et al.   CIRCULATION RESEARCH

Natriuretic peptides in cardiovascular diseases: current use and perspectives

(2013) M. Volpe et al.   EUROPEAN HEART JOURNAL

Atrial Natriuretic Peptide Genetic Variant rs5065 and Risk for Cardiovascular Disease in the General Community

(2013) Valentina Cannone et al.   HYPERTENSION

Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

(2013) Udaya S. Tantry et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus

(2013) Fabio Mangiacapra et al.   PLATELETS

Third universal definition of myocardial infarction

(2012) Kristian Thygesen et al.   EUROPEAN HEART JOURNAL

Influence of rs5065 Atrial Natriuretic Peptide Gene Variant on Coronary Artery Disease

(2012) Emanuele Barbato et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of Platelet Reactivity and Periprocedural Outcomes in Patients With Versus Without Diabetes Mellitus and Treated With Clopidogrel and Percutaneous Coronary Intervention

(2010) Fabio Mangiacapra et al.   AMERICAN JOURNAL OF CARDIOLOGY

Regulators of Platelet cAMP Levels: Clinical and Therapeutic Implications

(2010) L. Noe et al.   CURRENT MEDICINAL CHEMISTRY

NPR-C: a component of the natriuretic peptide family with implications in human diseases

(2010) Speranza Rubattu et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Factors Contributing to Increased Platelet Reactivity in People With Diabetes

(2009) D. J. Schneider   DIABETES CARE

Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro

(2009) Stefania Scarpino et al.   JOURNAL OF HYPERTENSION

Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular Diseases

(2008) S. Rubattu et al.   AMERICAN JOURNAL OF HYPERTENSION